期刊文献+

参芪地黄汤加减内服联合吴茱萸穴位贴敷治疗高血压肾病临床研究

Clinical Study on Oral Administration of Modified Shenqi Dihuang Decoction Combined with Point Application with Euodiae Fructus for Hypertensive Nephropathy
下载PDF
导出
摘要 目的:观察参芪地黄汤加减内服联合吴茱萸穴位贴敷治疗高血压肾病(HN)的临床疗效。方法:选取104例HN患者为研究对象,根据计算机程序随机分组法分为对照组与研究组各52例。对照组给予厄贝沙坦片治疗,研究组在对照组基础上加用参芪地黄汤加减联合吴茱萸穴位贴敷治疗。比较2组临床疗效、血压及肾功能指标[尿调节蛋白(UMOD)、肾小球滤过率(eGFR)]、炎症因子[转化生长因子-β1 (TGF-β1)、白细胞介素-6 (IL-6)]水平。结果:研究组总有效率为94.23%,高于对照组80.76%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组舒张压、收缩压均较治疗前降低(P<0.05),且研究组收缩压、舒张压均低于对照组(P<0.05)。治疗后,2组UMOD、eGFR水平均较治疗前升高(P<0.05),且研究组UMOD、eGFR水平均高于对照组(P<0.05)。治疗后,2组TGF-β1、IL-6水平均较治疗前降低(P<0.05),且研究组TGF-β1、IL-6水平均低于对照组(P<0.05)。结论:参芪地黄汤加减联合吴茱萸穴位贴敷治疗HN疗效显著,可缓解临床症状,减轻机体炎症反应,改善血压及肾功能。 Objective:To observe the clinical effect of the therapy of oral administration of Modified Shenqi Dihuang Decoction combined with point application with Euodiae Fructus on hypertensive nephrology(HN).Methods:A total of 104 HN patients were selected as the study subjects and divided into the control group and the study group according to the randomized grouping by computer program,with52 cases in each group.The control group was treated with Irbesartan Tablets,and the study group was additionally treated with Modified Shenqi Dihuang Decoction combined with point application with Euodiae Fructus.The clinical effects,blood pressure,and levels of indexes of kidney function,including uromodulin(UMOD) and estimated glomerular filtration rate(eGFR),and inflammatory factors,including transforming growth factor-β1(TGF-β1) and interleukin-6(IL-6),were compared between the two groups.Results:The total effective rate was 94.23% in the study group,higher than that of 80.76% in the control group,the difference being significant(P<0.05).After treatment,the diastolic and systolic pressure in both groups were decreased when compared with those before treatment(P<0.05),and the diastolic and systolic pressure in the study group were lower than those in the control group(P<0.05).After treatment,the levels of UMOD and eGFR in both groups were increased when compared with those before treatment(P<0.05),and the above levels in the study group were higher than those in the control group(P<0.05).After treatment,the levels of TGF-β1 and IL-6 in both groups were decreased when compared with those before treatment(P<0.05),and the above levels in the study group were lower than those in the control group(P<0.05).Conclusion:The therapy of oral administration of Modified Shenqi Dihuang Decoction combined with point application with Euodiae Fructus has a significant curative effect on HN,which can mitigate the clinical symptoms and inflammatory responses of the body,and improve the blood pressure and kidney function.
作者 赵薪薪 陈若如 林思思 赵浩靖 ZHAO Xinxin;CHEN Ruoru;LIN Sisi;ZHAO Haojing(Department of Nephrology,Wenzhou Traditional Chinese Medicine Hospital,Wenzhou Zhejiang 325300,China;Department of Gastroenterology,Wenzhou Traditional Chinese Medicine Hospital,Wenzhou Zhejiang 325300,China)
出处 《新中医》 CAS 2024年第2期160-164,共5页 New Chinese Medicine
关键词 高血压肾病 参芪地黄汤 吴茱萸 穴位贴敷 尿调节蛋白 肾小球滤过率 Hypertensive nephrology Shenqi Dihuang Decoction Euodiae Fructus Point application Uromodulin Glomerular filtration rate
  • 相关文献

参考文献15

二级参考文献137

  • 1董帅,王辉,谢治深.丹参功用本草考证及现代药理认识[J].辽宁中医药大学学报,2019,0(11):152-155. 被引量:93
  • 2马迎春,左力,王梅,周玉红,张春丽,徐国宾,王海燕.肾小球滤过率评估方程在慢性肾脏病不同分期中的适用性[J].中华内科杂志,2005,44(4):285-289. 被引量:82
  • 3Zheng-Ming Shi,Ping Feng,Dong-Qiao Jiang,Xue-Jiang Wang.Mistletoe alkali inhibits peroxidation in rat liver and kidney[J].World Journal of Gastroenterology,2006,12(25):4052-4055. 被引量:3
  • 4National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Am J Kidney Dis,2002,39(2 Suppl 1):S1-266.
  • 5Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.
  • 6Meguid EI,Nahas A,Bello AK.Chronic kidney disease:the global challenge.Lancet,2005,365:331-340.
  • 7Couser WG.Chronic kidney disease the promise and the perils.J Am Soc Nephrol,2007,18:2803-2805.
  • 8Hallan SI,Ritz E,Lydersen S,et al.Combining GFR and albuminuria to classify CKID improves prediction of ESRD.J Am Soc Nephrol,2009,20:1069-1077.
  • 9Zhang L,Zhang P,Wang F,et al.Prevalence and factors associated with CKD:a population study from Beijing.Am J Kidney Dis,2008,51:373-384.
  • 10Wen CP,Cheng TY,Tsai MK,et al.All-cause mortality attributable to chronic kidney disease:a prospective cohort study based on 462 293 adults in Taiwan.Lancet,2008,371:2173-2182.

共引文献362

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部